Eli Lilly will likely draw investor focus on Monday as the company said its investigational once-weekly insulin efsitora alfa ...

INDIANAPOLIS, Sept. 24, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon ...

But their budget expanded after pharmaceutical giant Eli Lilly announced on Mar. 1 that the monthly out-of-pocket prices of their insulin brands will soon be capped at $35 regardless of a person ...

Today, Lilly — the famous maker of weight-loss drug Zepbound and diabetes treatment Mounjaro — is the biggest health care stock on the S&P 500 with a market cap of almost $845.6 billion.

Drugmaker Eli Lilly on Thursday warned against using its diabetes and obesity drugs for “cosmetic” weight loss, as the medications have exploded in popularity, resulting in shortages. In an ...

Consumers in possession of Glucagon Emergency Kit lot D239382D should contact the Lilly Answers Center at 1-800-LILLYRX (1-800-545-5979) for return and replacement instructions for the product and ...

Eli Lilly issued a voluntary recall of a single lot of glucagon emergency kits used to treat severe hypoglycemia in diabetics after a patient reported a loss of drug potency and seizures.. Lilly ...

Eli Lilly recalled an emergency kit that can save the lives of people with diabetes having severe hypoglycemia. The reason: “loss of potency” after the kit failed a customer who needed it.

Eli Lilly is selling to Amphastar Pharmaceuticals global rights to Baqsimi, an emergency treatment for severe hypoglycemia in diabetes patients. The deal come as Lilly turns its focus to novel ...

The drugmaker Eli Lilly is cutting the list prices for its most popular insulin products by 70 percent and capping out-of-pocket costs at $35 per month, the company said Wednesday, as pressure moun… ...